Centre for Pain IMPACT (Investigating Mechanisms of Pain to Advance Clinical Translation), Neuroscience Research Australia, Sydney, Australia.
Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Perth, Australia.
JAMA. 2022 Aug 2;328(5):430-439. doi: 10.1001/jama.2022.9930.
The effects of altered neural processing, defined as altering neural networks responsible for perceptions of pain and function, on chronic pain remains unclear.
To estimate the effect of a graded sensorimotor retraining intervention (RESOLVE) on pain intensity in people with chronic low back pain.
DESIGN, SETTING, AND PARTICIPANTS: This parallel, 2-group, randomized clinical trial recruited participants with chronic (>3 months) nonspecific low back pain from primary care and community settings. A total of 276 adults were randomized (in a 1:1 ratio) to the intervention or sham procedure and attention control groups delivered by clinicians at a medical research institute in Sydney, Australia. The first participant was randomized on December 10, 2015, and the last was randomized on July 25, 2019. Follow-up was completed on February 3, 2020.
Participants randomized to the intervention group (n = 138) were asked to participate in 12 weekly clinical sessions and home training designed to educate them about and assist them with movement and physical activity while experiencing lower back pain. Participants randomized to the control group (n = 138) were asked to participate in 12 weekly clinical sessions and home training that required similar time as the intervention but did not focus on education, movement, and physical activity. The control group included sham laser and shortwave diathermy applied to the back and sham noninvasive brain stimulation.
The primary outcome was pain intensity at 18 weeks, measured on an 11-point numerical rating scale (range, 0 [no pain] to 10 [worst pain imaginable]) for which the between-group minimum clinically important difference is 1.0 point.
Among 276 randomized patients (mean [SD] age, 46 [14.3] years; 138 [50%] women), 261 (95%) completed follow-up at 18 weeks. The mean pain intensity was 5.6 at baseline and 3.1 at 18 weeks in the intervention group and 5.8 at baseline and 4.0 at 18 weeks in the control group, with an estimated between-group mean difference at 18 weeks of -1.0 point ([95% CI, -1.5 to -0.4]; P = .001), favoring the intervention group.
In this randomized clinical trial conducted at a single center among patients with chronic low back pain, graded sensorimotor retraining, compared with a sham procedure and attention control, significantly improved pain intensity at 18 weeks. The improvements in pain intensity were small, and further research is needed to understand the generalizability of the findings.
ANZCTR Identifier: ACTRN12615000610538.
改变神经处理的影响,即改变负责疼痛和功能感知的神经网络,对慢性疼痛的影响仍不清楚。
评估分级感觉运动再训练干预(RESOLVE)对慢性腰痛患者疼痛强度的影响。
设计、设置和参与者:这是一项平行的、2 组、随机临床试验,从初级保健和社区环境中招募了患有慢性(>3 个月)非特异性腰痛的参与者。共有 276 名成年人被随机分为干预组(n=138)或假手术组和注意对照组,并由澳大利亚悉尼的医学研究所的临床医生进行治疗。第一个参与者于 2015 年 12 月 10 日被随机分组,最后一个参与者于 2019 年 7 月 25 日被随机分组。随访于 2020 年 2 月 3 日完成。
随机分配到干预组的参与者(n=138)被要求参加 12 周的临床会议和家庭培训,旨在让他们了解运动和身体活动,并在体验下腰痛时协助他们进行运动和身体活动。随机分配到对照组的参与者(n=138)被要求参加 12 周的临床会议和家庭培训,该培训需要与干预组相同的时间,但不专注于教育、运动和身体活动。对照组包括应用于背部的假激光和短波透热疗法以及假非侵入性脑刺激。
主要结果是 18 周时的疼痛强度,采用 11 点数字评分量表(范围 0 [无痛]至 10 [可想象的最痛])进行测量,其组间最小临床重要差异为 1.0 分。
在 276 名随机患者中(平均[标准差]年龄,46[14.3]岁;138[50%]为女性),261 名(95%)在 18 周时完成了随访。干预组的平均疼痛强度基线为 5.6,18 周时为 3.1,对照组的平均疼痛强度基线为 5.8,18 周时为 4.0,干预组与对照组在 18 周时的平均差异估计为-1.0 点([95%置信区间,-1.5 至-0.4];P=0.001),有利于干预组。
在这项在慢性腰痛患者中进行的单中心随机临床试验中,分级感觉运动再训练与假手术和注意对照组相比,显著改善了 18 周时的疼痛强度。疼痛强度的改善很小,需要进一步研究来了解研究结果的普遍性。
澳大利亚新西兰临床试验注册中心标识符:ACTRN12615000610538。